source
- Biopharma firms urged to boost visibility with podcasts, webinars and thought-leadership programsThe guide released by BioSpace Insights outlines how biopharma communication teams can use emerging channels to raise their profile. It notes that while traditional media remains important, podcas…
- Axoltis Phase 2 ALS Trial Fails Primary Endpoint Though Shows Some Secondary TrendsAxoltis Pharma reported that its phase 2 study of the synthetic peptide NX210c in amyotrophic lateral sclerosis did not meet its primary goal. The double‑blind, randomized trial enrolled 82 French…